Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1193-1202

  Tabarin, A ^a   Valli, N ^a   Chanson, P ^b   Bachelot, Y ^c   Rohmer, V ^d   Bex Bachellerie, V ^a   Catargi, B ^a   Roger, P ^a   Laurent, F ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PENTETREOTIDE IN 111;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; LIVER METASTASIS; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

EID: 0033312609     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.4.5583     Document Type: Article

References (44)

1. Cushing's syndrome
2. Ectopic adrenocorticotropic hormone syndrome
3. Occult ectopic secretion of corticotropin
4. The Cushing's syndrome induced by bronchial carcinoid tumors
5. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: Early recognition of the ocuclt ectopic ACTH syndrome
6. Detection of ACTH-producing bronchial carcinoid tumors MR Imaging vs. CT
7. Biochemical and radiologic diagnosis of Cushing's syndrome
8. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
9. 123I-Tyr 3)-octreotide: The Rotterdam experience with more than 1000 patients
10. Somatostatin analogs in ectopic corticotropin production
11. Somatostatin receptor scintigraphy: Its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion
12. Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy
13. Somatostatin analogs for the localization an preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor
14. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy
15. Charaterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome
16. Bronchial carcinoid associated with Cushing's syndrome
17. Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111 indium-DTPA labelled octreotide
18. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor
19. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy
20. Characterizing an ectopic secreting carcinoid with Indium-111-DTPA-D-Phe-Pentetreotide
21. Imaging of bronchial carcinoid tumors associated to Cushing's syndrome with 111In-Octreoscan scintigraphy and immunoscintigraphy with anti-chromogranin monoclonal antibodies
22. Localization and postoperative follow-up of a bronchial tumor causing Cushing's syndrome by 111In-DTPA labelled octreotide scintigraphy
23. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid
24. Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome
25. Bronciopulmonary carcinoid tumors associated with Cushing's syndrome: A more aggressive variant of typical carcinoid
26. Ectopic ACTH syndrome and pulmonary carcinoid tumour identified by [111-In-DTPA-D-Phe1] octreotide
27. Clinical problem-solving
28. Somatostatin-receptor-negative carcinoid tumor responsible for Cushing's syndrome
29. Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion
30. Usefulness of the corticotrophin-releasing hormone test during bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's disease
31. Comparative value of plasma ACTH and β-endorphin using three different commercial kits for hte etiological diagnosis of ACTH-dependent Cushing's syndrome
32. The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: A comparison with the lysine-vasopressin test
33. Somatostatin receptor scintigraphy and the ectopic ACTH syndrome. The solution or just another test?
34. Somatostatin receptor scintigraphy in forty-eight patients with Zollinger-Ellison syndrome
35. Somatostatin receptor scintigraphy for the diagnosis of neuroendocrine tumors
36. Adrenocorticotropic hormone-secreting islet cell tumors: Are they always malignant?
37. Diagnosis and management of ACTH-dependent Cushing's syndrome: Comparison of the features in ectopic and pituitary ACTH production
38. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
39. Disorders of vasodilator hormones: Carcinoid syndrome and mastocytosis
40. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical and flow cytometry study of 35 cases
41. Octreotide exerts different effects in vivo and in vitro in Cushing's disease
42. Editorial: A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome
43. Syndrome de Cushing revelateur d'un carcinome neuroendocrine bronchique: interet de la scintigraphie a l'octreotide
44. Predicting the effects of long term medical treatment in acromegaly. AT what cost? and for what benefit?